Dissociation of lipopolysaccharide (LPS)-inducible gene expression in murine macrophages pretreated with smooth LPS versus monophosphoryl lipid A
暂无分享,去创建一个
C. Manthey | S. Vogel | T. Hamilton | P. Perera | T A Hamilton | C L Manthey | B E Henricson | P Y Perera | S N Vogel | B. Henricson | C. L. Manthey | S. N. Vogel | T. A. Hamilton | T. A. Hamilton | C. Manthey
[1] S. N. Vogel,et al. An interleukin-1 receptor antagonist blocks lipopolysaccharide-induced colony-stimulating factor production and early endotoxin tolerance , 1991, Infection and immunity.
[2] S. Vogel,et al. Early endotoxin tolerance is associated with alterations in bone marrow-derived macrophage precursor pools. , 1985, Journal of immunology.
[3] S. Vogel,et al. IFN-gamma mediates increased glucocorticoid receptor expression in murine macrophages. , 1992, Journal of immunology.
[4] J. Sambrook,et al. Molecular Cloning: A Laboratory Manual , 2001 .
[5] T. Hamilton,et al. Inducible expression of murine IP-10 mRNA varies with the state of macrophage inflammatory activity. , 1991, Journal of immunology.
[6] C. Galanos,et al. Induction of tolerance to lipopolysaccharide (LPS)-D-galactosamine lethality by pretreatment with LPS is mediated by macrophages , 1988, Infection and immunity.
[7] Y. Ohmori,et al. A macrophage LPS-inducible early gene encodes the murine homologue of IP-10. , 1990, Biochemical and biophysical research communications.
[8] S. Zuckerman,et al. Endotoxin-macrophage interaction: post-translational regulation of tumor necrosis factor expression. , 1989, Journal of immunology.
[9] R. Ulevitch,et al. Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits. , 1988, The Journal of clinical investigation.
[10] S. N. Vogel,et al. Differential inhibition of lipopolysaccharide-induced phenomena by anti-tumor necrosis factor alpha antibody , 1990, Infection and immunity.
[11] J. Haas,et al. Downregulation of Tumor Necrosis Factor Expression in the Human Mono‐Mac‐6 Cell Line by Lipopolysaccharide , 1989, Journal of leukocyte biology.
[12] C. Tannenbaum,et al. Characterization of lipopolysaccharide-induced macrophage gene expression. , 1988, Journal of immunology.
[13] K. Glaser,et al. Lipopolysaccharide induces hyporesponsiveness to its own action in RAW 264.7 cells. , 1989, The Journal of biological chemistry.
[14] W. Rutter,et al. Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.
[15] E. Coligan. Current protocols in immunology , 1991 .
[16] C. Nathan,et al. Macrophages rapidly internalize their tumor necrosis factor receptors in response to bacterial lipopolysaccharide. , 1989, The Journal of biological chemistry.
[17] S. Zuckerman,et al. Endotoxin tolerance: independent regulation of interleukin-1 and tumor necrosis factor expression , 1991, Infection and immunity.
[18] C. Tannenbaum,et al. Lipopolysaccharide-induced gene expression in murine peritoneal macrophages is selectively suppressed by agents that elevate intracellular cAMP. , 1989, Journal of immunology.
[19] S. Vogel,et al. Induction of early-phase endotoxin tolerance in athymic (nude) mice, B-cell-deficient (xid) mice, and splenectomized mice , 1986, Infection and immunity.
[20] S. Vogel,et al. Rhodopseudomonas sphaeroides lipid A derivatives block in vitro induction of tumor necrosis factor and endotoxin tolerance by smooth lipopolysaccharide and monophosphoryl lipid A , 1992, Infection and immunity.
[21] Andrew D. Luster,et al. γ-Interferon transcriptionally regulates an early-response gene containing homology to platelet proteins , 1985, Nature.
[22] S. Sakiyama,et al. Nucleotide sequence of a full-length cDNA for mouse cytoskeletal beta-actin mRNA. , 1986, Nucleic acids research.
[23] J. Hiernaux,et al. Immunomodulatory activity of monophosphoryl lipid A in C3H/HeJ and C3H/HeSnJ mice , 1989, Infection and immunity.
[24] L. Tartaglia,et al. The two different receptors for tumor necrosis factor mediate distinct cellular responses. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[25] D. Goeddel,et al. Cloning and expression in Escherichia coli of the cDNA for murine tumor necrosis factor. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[26] S. Vogel,et al. Early-phase endotoxin tolerance: induction by a detoxified lipid A derivative, monophosphoryl lipid A , 1986, Infection and Immunity.
[27] W. Benjamin,et al. Differential cytokine induction by doses of lipopolysaccharide and monophosphoryl lipid A that result in equivalent early endotoxin tolerance , 1990, Infection and immunity.
[28] E. Ribi. Beneficial modification of the endotoxin molecule. , 1984, Journal of biological response modifiers.
[29] Increase in National Hospital Discharge Survey rates for septicemia--United States, 1979-1987. , 1990, MMWR. Morbidity and mortality weekly report.
[30] R. Gentz,et al. Both tumor necrosis factor receptor types mediate proliferative signals in human mononuclear cell activation. , 1992, Journal of immunology.
[31] J. Haas,et al. Molecular mechanisms in down-regulation of tumor necrosis factor expression. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[32] C. Tannenbaum,et al. Lipopolysaccharide-inducible macrophage early genes are induced in Balb/c 3T3 cells by platelet-derived growth factor. , 1989, The Journal of biological chemistry.
[33] C. Manthey,et al. Taxol increases steady-state levels of lipopolysaccharide-inducible genes and protein-tyrosine phosphorylation in murine macrophages. , 1992, Journal of immunology.